Biomarkers in Nonalcoholic Fatty Liver Disease
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition characterized by insulin resistance, type 2 diabetes and fat accumulation in the liver that may cause hepatic inflammation and progressive scarring leading to nonalcoholic steatohepatitis (NASH) and irreversible liver...
Saved in:
| Main Authors: | Manuela G Neuman, Lawrence B Cohen, Radu M Nanau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2014/757929 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonmedicinal Interventions in Nonalcoholic Fatty Liver Disease
by: Manuela G Neuman, et al.
Published: (2015-01-01) -
Multiple Factors Involved in Nonalcoholic Hepatitis Pathogenesis
by: Manuela Neuman, et al.
Published: (2012-01-01) -
Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01) -
HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury
by: Manuela G. Neuman, et al.
Published: (2012-01-01) -
Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)